UniProt ID | 2A5A_HUMAN | |
---|---|---|
UniProt AC | Q15172 | |
Protein Name | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | |
Gene Name | PPP2R5A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 486 | |
Subcellular Localization | Cytoplasm . Nucleus . Chromosome, centromere . From mitotic prophase to metaphase, localizes at the inner centromere between a pair of sister kinetochores. Decreased expression at the onset of anaphase. | |
Protein Description | The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment.. | |
Protein Sequence | MSSSSPPAGAASAAISASEKVDGFTRKSVRKAQRQKRSQGSSQFRSQGSQAELHPLPQLKDATSNEQQELFCQKLQQCCILFDFMDSVSDLKSKEIKRATLNELVEYVSTNRGVIVESAYSDIVKMISANIFRTLPPSDNPDFDPEEDEPTLEASWPHIQLVYEFFLRFLESPDFQPSIAKRYIDQKFVQQLLELFDSEDPRERDFLKTVLHRIYGKFLGLRAFIRKQINNIFLRFIYETEHFNGVAELLEILGSIINGFALPLKAEHKQFLMKVLIPMHTAKGLALFHAQLAYCVVQFLEKDTTLTEPVIRGLLKFWPKTCSQKEVMFLGEIEEILDVIEPTQFKKIEEPLFKQISKCVSSSHFQVAERALYFWNNEYILSLIEENIDKILPIMFASLYKISKEHWNPTIVALVYNVLKTLMEMNGKLFDDLTSSYKAERQREKKKELEREELWKKLEELKLKKALEKQNSAYNMHSILSNTSAE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSSSPPAG ------CCCCCCCCH | 38.64 | 25850435 | |
2 | Acetylation | ------MSSSSPPAG ------CCCCCCCCH | 38.64 | 22223895 | |
3 | Phosphorylation | -----MSSSSPPAGA -----CCCCCCCCHH | 33.27 | 25850435 | |
4 | Phosphorylation | ----MSSSSPPAGAA ----CCCCCCCCHHH | 39.29 | 25850435 | |
5 | Phosphorylation | ---MSSSSPPAGAAS ---CCCCCCCCHHHH | 36.53 | 25850435 | |
12 | Phosphorylation | SPPAGAASAAISASE CCCCHHHHHHHHHHH | 20.07 | 25850435 | |
16 | Phosphorylation | GAASAAISASEKVDG HHHHHHHHHHHHCCC | 22.48 | 28270605 | |
18 | Phosphorylation | ASAAISASEKVDGFT HHHHHHHHHHCCCCC | 31.03 | 28270605 | |
25 | Phosphorylation | SEKVDGFTRKSVRKA HHHCCCCCHHHHHHH | 42.59 | 24719451 | |
28 | Phosphorylation | VDGFTRKSVRKAQRQ CCCCCHHHHHHHHHH | 24.70 | 22817900 | |
38 | Phosphorylation | KAQRQKRSQGSSQFR HHHHHHHHCCCHHHH | 46.02 | 25159151 | |
41 | Phosphorylation | RQKRSQGSSQFRSQG HHHHHCCCHHHHHCC | 17.21 | 26846344 | |
42 | Phosphorylation | QKRSQGSSQFRSQGS HHHHCCCHHHHHCCC | 39.91 | 26846344 | |
46 | Phosphorylation | QGSSQFRSQGSQAEL CCCHHHHHCCCCCEE | 39.93 | 25159151 | |
49 | Phosphorylation | SQFRSQGSQAELHPL HHHHHCCCCCEECCC | 20.69 | 25159151 | |
100 | Phosphorylation | SKEIKRATLNELVEY CHHHHHHHHHHHHHH | 33.86 | 26074081 | |
107 | Phosphorylation | TLNELVEYVSTNRGV HHHHHHHHHHCCCCE | 7.69 | 26074081 | |
109 | Phosphorylation | NELVEYVSTNRGVIV HHHHHHHHCCCCEEE | 21.04 | 26074081 | |
110 | Phosphorylation | ELVEYVSTNRGVIVE HHHHHHHCCCCEEEC | 20.92 | 26074081 | |
118 | Phosphorylation | NRGVIVESAYSDIVK CCCEEECCHHHHHHH | 22.93 | 26074081 | |
120 | Phosphorylation | GVIVESAYSDIVKMI CEEECCHHHHHHHHH | 19.02 | 26074081 | |
121 | Phosphorylation | VIVESAYSDIVKMIS EEECCHHHHHHHHHH | 22.15 | 26074081 | |
181 | Malonylation | DFQPSIAKRYIDQKF CCCHHHHHHHCCHHH | 44.03 | 26320211 | |
181 | Acetylation | DFQPSIAKRYIDQKF CCCHHHHHHHCCHHH | 44.03 | 25953088 | |
217 | Ubiquitination | VLHRIYGKFLGLRAF HHHHHHHHHHCHHHH | 22.05 | - | |
259 | Ubiquitination | ILGSIINGFALPLKA HHHHHHHCCCCCCCH | 9.97 | 21890473 | |
263 | Ubiquitination | IINGFALPLKAEHKQ HHHCCCCCCCHHHHH | 28.52 | 22817900 | |
281 | Phosphorylation | KVLIPMHTAKGLALF HHHHHHHHHHHHHHH | 24.66 | 26434552 | |
316 | Ubiquitination | PVIRGLLKFWPKTCS HHHHHHHHHCCCCCC | 50.88 | 21890473 | |
316 | Ubiquitination | PVIRGLLKFWPKTCS HHHHHHHHHCCCCCC | 50.88 | 21890473 | |
320 | Ubiquitination | GLLKFWPKTCSQKEV HHHHHCCCCCCCHHE | 53.40 | 22817900 | |
361 | Phosphorylation | KQISKCVSSSHFQVA HHHHHHCCCHHHHHH | 35.28 | 29083192 | |
362 | Phosphorylation | QISKCVSSSHFQVAE HHHHHCCCHHHHHHH | 13.87 | 29083192 | |
363 | Phosphorylation | ISKCVSSSHFQVAER HHHHCCCHHHHHHHH | 22.33 | 29083192 | |
381 | Ubiquitination | FWNNEYILSLIEENI HHCCHHHHHHHHHCH | 3.14 | 29967540 | |
412 | Ubiquitination | EHWNPTIVALVYNVL HHCCHHHHHHHHHHH | 3.56 | 29967540 | |
421 | Phosphorylation | LVYNVLKTLMEMNGK HHHHHHHHHHHHCCH | 27.46 | 24719451 | |
438 | Ubiquitination | DDLTSSYKAERQREK HHHHHHHHHHHHHHH | 45.80 | 29967540 | |
457 | Ubiquitination | EREELWKKLEELKLK HHHHHHHHHHHHHHH | 49.93 | - | |
469 | Ubiquitination | KLKKALEKQNSAYNM HHHHHHHHCCCCHHH | 56.48 | 29967540 | |
472 | Phosphorylation | KALEKQNSAYNMHSI HHHHHCCCCHHHHHH | 29.63 | 20068231 | |
474 | Phosphorylation | LEKQNSAYNMHSILS HHHCCCCHHHHHHHH | 16.91 | 20068231 | |
478 | Phosphorylation | NSAYNMHSILSNTSA CCCHHHHHHHHCCCC | 17.92 | 25159151 | |
481 | Phosphorylation | YNMHSILSNTSAE-- HHHHHHHHCCCCC-- | 36.07 | 20068231 | |
484 | Phosphorylation | HSILSNTSAE----- HHHHHCCCCC----- | 34.35 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 2A5A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 2A5A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
2A5G_HUMAN | PPP2R5C | physical | 11929880 | |
2AAA_HUMAN | PPP2R1A | physical | 18782753 | |
PP2AA_HUMAN | PPP2CA | physical | 18782753 | |
2AAB_HUMAN | PPP2R1B | physical | 18782753 | |
AXIN1_HUMAN | AXIN1 | physical | 11297546 | |
PP2AA_HUMAN | PPP2CA | physical | 8703017 | |
2AAB_HUMAN | PPP2R1B | physical | 8703017 | |
CCNG1_MOUSE | Ccng1 | physical | 11983168 | |
PTTG1_HUMAN | PTTG1 | physical | 24781523 | |
DAPK1_HUMAN | DAPK1 | physical | 20220139 | |
PP2AA_HUMAN | PPP2CA | physical | 20220139 | |
2AAA_HUMAN | PPP2R1A | physical | 20220139 | |
2ABD_HUMAN | PPP2R2D | physical | 20220139 | |
2A5D_HUMAN | PPP2R5D | physical | 26344197 | |
PP2AA_HUMAN | PPP2CA | physical | 26811472 | |
BUB1B_HUMAN | BUB1B | physical | 26811472 | |
CDC20_HUMAN | CDC20 | physical | 26811472 | |
UBE2S_HUMAN | UBE2S | physical | 26811472 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-42, AND MASSSPECTROMETRY. |